Remarkably, ALS-linked mutations in the PrLD of hnRNPA1 and FUS accelerate transitions from liquid to gel states, which likely accelerates disease (Molliex et al., 2015; Patel et al., 2015). The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.